Ausgabe 3/2018
Inhalt (26 Artikel)
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
Ricardo L. B. Costa, Hyo Sook Han, William J. Gradishar
First international TNBC conference meeting report
Padmashree Rida, Angela Ogden, Ian O. Ellis, Zsuzsanna Varga, Antonio C. Wolff, Tiffany A. Traina, Christos Hatzis, Julie R. Palmer, Christine B. Ambrosone, Brian D. Lehmann, Rita Nanda, Valerie Montgomery Rice, Otis W. Brawley, Mylin A. Torres, Emad Rakha, Ritu Aneja
Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis
Hadar Goldvaser, Habeeb Majeed, Domen Ribnikar, Boštjan Šeruga, Alberto Ocaña, David W. Cescon, Eitan Amir
Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes
Neda Zarei, Mehdi Fazeli, Mozafar Mohammadi, Foroogh Nejatollahi
Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer
Kanae K. Miyake, Yuji Nakamoto, Shigehira Saji, Tomoharu Sugie, Kensuke Kurihara, Shotaro Kanao, Debra M. Ikeda, Masakazu Toi, Kaori Togashi
Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy
Yuri Tolkach, Heidrun Gevensleben, Ralph Bundschuh, Aydan Koyun, Daniela Huber, Christina Kehrer, Thomas Hecking, Mignon-Denise Keyver-Paik, Christina Kaiser, Hojjat Ahmadzadehfar, Markus Essler, Walther Kuhn, Glen Kristiansen
A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer
M. Rudolph, S. T. Sizemore, Y. Lu, K. Y. Teng, M. M. Basree, R. Reinbolt, C. D. Timmers, G. Leone, M. C. Ostrowski, S. Majumder, B. Ramaswamy
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial
Wolfgang Janni, Emilio Alba, Thomas Bachelot, Sami Diab, Miguel Gil-Gil, Thaddeus J. Beck, Larisa Ryvo, Rafael Lopez, Michaela Tsai, Francisco J. Esteva, Pilar Zamora Auñón, Zdenek Kral, Patrick Ward, Paul Richards, Timothy J. Pluard, Santosh Sutradhar, Michelle Miller, Mario Campone
Breast cancer subtype and survival by parity and time since last birth
H. De Mulder, A. Laenen, H. Wildiers, K. Punie, A. Poppe, C. Remmerie, H. Lefrère, I. Nevelsteen, A. Smeets, E. Van Nieuwenhuysen, S. Han, E. Van Limbergen, G. Floris, I. Vergote, P. Neven
Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial
Per Skaane, Sofie Sebuødegård, Andriy I. Bandos, David Gur, Bjørn Helge Østerås, Randi Gullien, Solveig Hofvind
Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial
Kim C. Aalders, Nathan Touati, Konstantinos Tryfonidis, Mylène Annonay, Saskia Litiere, Jonas Bergh, Alexandre Bodmer, David A. Cameron, Hervé R. Bonnefoi
Chest wall recurrence in pT1-2N0-1 breast cancer patients after mastectomy without radiotherapy
Ji Hyun Chang, Kyung Hwan Shin, Seung Do Ahn, Hae Jin Park, Eui Kyu Chie, Jin Ho Kim, Su Ssan Kim, Yong Bae Kim, Won Park, Yeon-Joo Kim, Hyun Soo Shin, Jin Hee Kim, Sun Young Lee, Kyubo Kim, Kyung Ran Park, Bae Kwon Jeong, Ja Young Kim, Suzy Kim
The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery
Angela Collarino, Renato A. Valdés Olmos, Lotta G. A. J. van Berkel, Peter A. Neijenhuis, Lidy M. H. Wijers, Frederik Smit, Lioe-Fee de Geus-Oei, Lenka M. Pereira Arias-Bouda
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer
Farrokh Dehdashti, Ningying Wu, Ron Bose, Michael J. Naughton, Cynthia X. Ma, Bernadette V. Marquez-Nostra, Philipp Diebolder, Cedric Mpoy, Buck E. Rogers, Suzanne E. Lapi, Richard Laforest, Barry A. Siegel
Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study
James R. Harvey, Yit Lim, John Murphy, Miles Howe, Julie Morris, Amit Goyal, Anthony J. Maxwell
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
Lynne I. Wagner, Fengmin Zhao, Paul E. Goss, Judith-Anne W. Chapman, Lois E. Shepherd, Timothy J. Whelan, Bassam I. Mattar, Jose A. Bufill, William C. Schultz, Irving E. LaFrancis, Gauri G. Nagargoje, Radhakrishna Vemuri, Daniel A. Nikcevich, George W. Sledge, David Cella
Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients
D. H. M. Jacobs, G. Speijer, A. L. Petoukhova, E. M. A. Roeloffzen, M. Straver, A. Marinelli, U. Fisscher, A. G. Zwanenburg, J. Merkus, C. A. M. Marijnen, M. E. Mast, P. C. M. Koper
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Jacqueline Lammert, Jan Lubinski, Jacek Gronwald, Tomasz Huzarski, Susan Armel, Andrea Eisen, Wendy S. Meschino, Henry T. Lynch, Carrie Snyder, Charis Eng, Olufunmilayo I. Olopade, Ophira Ginsburg, William D. Foulkes, Christine Elser, Stephanie A. Cohen, Marion Kiechle, Steven A. Narod, Joanne Kotsopoulos
Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18–64 years in BCBS of Texas
Junghyun Kim, Suja S. Rajan, Xianglin L. Du, Luisa Franzini, Sharon H. Giordano, Robert O. Morgan
A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis
Vasily Giannakeas, Victoria Sopik, Steven A. Narod
Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013
Meredith L. Shoemaker, Mary C. White, Manxia Wu, Hannah K. Weir, Isabelle Romieu
Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare population
Catherine Schairer, D. Michal Freedman, Shahinaz M. Gadalla, Ruth M. Pfeiffer
Factors associated with improved outcomes for metastatic inflammatory breast cancer patients
Anna Weiss, Rhiana S. Menen, Heather Y. Lin, Yu Shen, Kelly J. Rosso, Simona Shaitelman, Wendy Woodward, Vicente Valero, Naoto T. Ueno, Isabelle Bedrosian, Gildy Babiera
MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicine
Bingbing Xie, Zifeng Yuan, Yadong Yang, Zhidan Sun, Shuigeng Zhou, Xiangdong Fang
Is invasion a necessary step for metastases in breast cancer? Narod SA, Sopik V
Alan B. Hollingsworth
Reply to Hollingsworth: does breast cancer metastasize in the clinical window between the mammogram and the mass?
Steven A. Narod